NIH Stroke Scale (NIHSS) Calculator
Quantify stroke severity using the 11-domain NIH Stroke Scale. Score range: 0–42.
Inputs
Disclaimer: For educational purposes only. Not a substitute for clinical judgment.
About This Tool
What Is the NIH Stroke Scale?
The National Institutes of Health Stroke Scale (NIHSS) is a standardized clinical assessment tool developed by Thomas Brott and colleagues in 1989 to quantify the severity of neurological deficits caused by acute ischemic stroke. It evaluates 11 domains across 15 items, producing a total score from 0 (no deficit) to 42 (maximum severity). The NIHSS has become the standard for stroke severity assessment worldwide and is used in emergency departments, stroke units, and clinical trials to guide treatment decisions and track patient progress.
How to Perform the NIHSS
The NIHSS should be performed in the order listed, scoring each item based on the first response observed — do not coach or repeat instructions. Each item is scored on an ordinal scale, with 0 representing normal function. The motor arm and leg items are tested individually for left and right sides. Items that cannot be tested due to pre-existing conditions (e.g., amputation, joint fusion) are scored as "UN" (untestable) and count as 0 toward the total. The entire assessment typically takes 5–8 minutes to complete.
Clinical Significance
The NIHSS score correlates with infarct volume, functional outcome, and mortality. Scores of 1–4 indicate minor stroke with generally good prognosis, while scores >20 suggest severe stroke with high mortality risk. The NIHSS is used to guide decisions about intravenous thrombolysis (alteplase), mechanical thrombectomy, and level of care. Serial NIHSS measurements help detect clinical deterioration (e.g., stroke progression, hemorrhagic transformation) and measure treatment response.
🔑 Clinical Pearls
- The NIHSS is weighted toward anterior circulation deficits — it may underestimate posterior circulation (vertebrobasilar) strokes, which can be catastrophic despite low scores.
- A change of ≥4 points on serial NIHSS is generally considered clinically significant and should prompt reassessment.
- For tPA eligibility, there is no strict NIHSS cutoff, but scores >25 carry increased hemorrhagic risk. "Mild but disabling" symptoms (low NIHSS) may still warrant treatment.
- NIHSS certification requires formal training — ensure examiners are certified for accurate, reproducible scoring.
Key References
- Brott T, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864-870.
- NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1587.
- Powers WJ, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update. Stroke. 2019;50(12):e344-e418.
Formula last verified: February 2026